The use of drug delivery devices to deliver them through the skin is not a new concept. Using a needle and syringe combination has been going on for decades. Advanced dermatological drug delivery device is based on the concept of drug delivery, with additional functions to reduce pain, improve drug compliance, consumer participation, user-friendly design, and easy management.
These devices include syringes, patches, dispensers and vacuum bottles, leather pumps, valves, and additional devices to increase safety and enhance connectivity.
The market for advanced drug delivery devices is growing rapidly, and some of these products are well suited for use in low- and middle-income countries. Increasing awareness of networked devices and the benefits of painless drug administration, especially in emerging countries, is also expected to drive sales growth for such devices.
Recently, LITT also referred to as laser-thermo ablation, has provided stereotactic neurosurgery with a new option for minimally invasive treatment of brain tissue. In real-time Magnetic Resonance Imaging (MRI) procedures, LITT relies on a laser catheter inserted into the skull through a small hole to deliver laser light, usually at a wavelength of 980 nm or 1064 nm.
As stated by BIS Research, the global advanced dermatology drug delivery devices market report highlights that the market was valued at $3,348.9 million in 2020 and is expected to reach $8,783.0 million by the end of 2030. The market is expected to grow at a CAGR of 10.52% during the forecast period 2021-2030.
Currently, the factors driving market growth according to the global premium dermatology delivery devices market report include the global push toward connected devices, increasing number of business partnerships, joint ventures with pharmaceutical companies, new drug delivery technologies, and an increasing focus on prescription compliance.
As part of contract manufacturing, companies operating in the global advanced dermatological drug delivery device market place great emphasis on partnerships, alliances, and business expansion. Many products, like delivery equipment in the market are sold with drugs, making commercial synergies crucial in the market. Several companies in the market have been participating in the equipment development plan for such devices, and their products are under development.
Hospitals are the primary end users for the global advanced dermatology delivery devices market. Other end users are dermatology practices and home use.
It is expected that future innovations will be driven by additional features that provide convenience to consumers/patients in the epicenter. Market participants are expected to differentiate their products based on characteristics, technologies used, services provided, and ease of use of equipment.
